Last 4,871 GBp
Change Today -20.00 / -0.41%
Volume 3.3M
SHP On Other Exchanges
Symbol
Exchange
SHP is not on other exchanges.
As of 11:35 AM 08/1/14 All times are local (Market data is delayed by at least 15 minutes).

Executive Profile*

Mike Yasick

Interim Head of Specialty Pharma Business, Shire plc
AgeTotal Calculated CompensationThis person is connected to 0 board members in 0 different organizations across 1 different industries.

----

Background*

Mr. Mike Yasick has been an Interim Head of Specialty Pharma Business at Shire plc since May 2013. Mr. Yasick has been with Shire plc about 8 years now, has been running, he has been running that for just over 5 years and has really been a tremendous agent, again, pre-evolution and change to keep business really at the leading edge of ADHD treatment and patient therapy. Prior to that, in his other 3 years, he was actually leading GI business. So, he almost more than ...

Read Full Background

Corporate Headquarters*

5 Riverwalk
Dublin, Co. Dublin 24

Ireland

Phone: 353 1 429 7700
Fax: --

Board Members Memberships*

There is no Board Members Memberships data available.

Education*

There is no Education data available.

Other Affiliations*

There is no Company Affiliations data available.

Annual Compensation*

There is no Annual Compensation data available.

Stock Options*

There is no Stock Options data available.

Total Compensation*

There is no Total Compensation data available.
*Data is at least as current as the most recent Definitive Proxy.
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
SHP:LN 4,871.00 GBp -20.00

COMPETITOR COMPENSATION

NamePosition/
Company
Compensation
Brenton L. Saunders J.D.Chief Executive Officer, President and Director
Actavis plc
--
David E. I. Pyott Chairman and Chief Executive Officer
Allergan Inc.
$1.4M
Robert J. Hugin MBAChairman, Chief Executive Officer, President and Chairman of Executive Committee
Celgene Corporation
$1.3M
J. Michael Pearson Chairman and Chief Executive Officer
Valeant Pharmaceuticals International, Inc.
$1.8M
Paul R. Perreault BA PsychologyChief Executive Officer, Managing Director, Executive Director and Member of Innovation & Development Committee
CSL Ltd.
$1.9M
Compensation as of Fiscal Year --.

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact SHIRE PLC, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.